Cargando…

Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis

BACKGROUND: The worldwide organ shortage continues to be the main limitation of liver transplantation. To bridge the gap between the demand and supply of liver grafts, it becomes necessary to use extended criteria donor livers for transplantation. Hypothermic machine perfusion (HMP) is designed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yili, Zhang, Yangmin, Zhang, Mei, Ma, Zhenhua, Wu, Shengli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571373/
https://www.ncbi.nlm.nih.gov/pubmed/31169745
http://dx.doi.org/10.1097/MD.0000000000016033
_version_ 1783427401260204032
author Zhang, Yili
Zhang, Yangmin
Zhang, Mei
Ma, Zhenhua
Wu, Shengli
author_facet Zhang, Yili
Zhang, Yangmin
Zhang, Mei
Ma, Zhenhua
Wu, Shengli
author_sort Zhang, Yili
collection PubMed
description BACKGROUND: The worldwide organ shortage continues to be the main limitation of liver transplantation. To bridge the gap between the demand and supply of liver grafts, it becomes necessary to use extended criteria donor livers for transplantation. Hypothermic machine perfusion (HMP) is designed to improve the quality of preserved organs before implantation. In clinical liver transplantation, HMP is still in its infancy. METHODS: A systematic search of the PubMed, EMBASE, Springer, and Cochrane Library databases was performed to identify studies comparing the outcomes in patients with HMP versus static cold storage (SCS) of liver grafts. The parameters analyzed included the incidences of primary nonfunction (PNF), early allograft dysfunction (EAD), vascular complications, biliary complications, length of hospital stay, and 1-year graft survival. RESULTS: A total of 6 studies qualified for the review, involving 144 and 178 liver grafts with HMP or SCS preservation, respectively. The incidences of EAD and biliary complications were significantly reduced with an odds ratio (OR) of 0.36 (95% confidence interval [CI] 0.17–0.77, P = .008) and 0.47 (95% CI 0.28–0.76, P = .003), respectively, and 1-year graft survival was significantly increased with an OR of 2.19 (95% CI 1.14–4.20, P = .02) in HMP preservation compared to SCS. However, there was no difference in the incidence of PNF (OR 0.30, 95% CI 0.06–1.47, P = .14), vascular complications (OR 0.69, 95% CI 0.29–1.66, P = .41), and the length of hospital stay (mean difference −0.30, 95% CI −4.10 to 3.50, P = .88) between HMP and SCS preservation. CONCLUSIONS: HMP was associated with a reduced incidence of EAD and biliary complications, as well as an increased 1-year graft survival, but it was not associated with the incidence of PNF, vascular complications, and the length of hospital stay.
format Online
Article
Text
id pubmed-6571373
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-65713732019-07-22 Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis Zhang, Yili Zhang, Yangmin Zhang, Mei Ma, Zhenhua Wu, Shengli Medicine (Baltimore) Research Article BACKGROUND: The worldwide organ shortage continues to be the main limitation of liver transplantation. To bridge the gap between the demand and supply of liver grafts, it becomes necessary to use extended criteria donor livers for transplantation. Hypothermic machine perfusion (HMP) is designed to improve the quality of preserved organs before implantation. In clinical liver transplantation, HMP is still in its infancy. METHODS: A systematic search of the PubMed, EMBASE, Springer, and Cochrane Library databases was performed to identify studies comparing the outcomes in patients with HMP versus static cold storage (SCS) of liver grafts. The parameters analyzed included the incidences of primary nonfunction (PNF), early allograft dysfunction (EAD), vascular complications, biliary complications, length of hospital stay, and 1-year graft survival. RESULTS: A total of 6 studies qualified for the review, involving 144 and 178 liver grafts with HMP or SCS preservation, respectively. The incidences of EAD and biliary complications were significantly reduced with an odds ratio (OR) of 0.36 (95% confidence interval [CI] 0.17–0.77, P = .008) and 0.47 (95% CI 0.28–0.76, P = .003), respectively, and 1-year graft survival was significantly increased with an OR of 2.19 (95% CI 1.14–4.20, P = .02) in HMP preservation compared to SCS. However, there was no difference in the incidence of PNF (OR 0.30, 95% CI 0.06–1.47, P = .14), vascular complications (OR 0.69, 95% CI 0.29–1.66, P = .41), and the length of hospital stay (mean difference −0.30, 95% CI −4.10 to 3.50, P = .88) between HMP and SCS preservation. CONCLUSIONS: HMP was associated with a reduced incidence of EAD and biliary complications, as well as an increased 1-year graft survival, but it was not associated with the incidence of PNF, vascular complications, and the length of hospital stay. Wolters Kluwer Health 2019-06-07 /pmc/articles/PMC6571373/ /pubmed/31169745 http://dx.doi.org/10.1097/MD.0000000000016033 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Zhang, Yili
Zhang, Yangmin
Zhang, Mei
Ma, Zhenhua
Wu, Shengli
Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis
title Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis
title_full Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis
title_fullStr Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis
title_full_unstemmed Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis
title_short Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: A meta-analysis
title_sort hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571373/
https://www.ncbi.nlm.nih.gov/pubmed/31169745
http://dx.doi.org/10.1097/MD.0000000000016033
work_keys_str_mv AT zhangyili hypothermicmachineperfusionreducestheincidencesofearlyallograftdysfunctionandbiliarycomplicationsandimproves1yeargraftsurvivalafterhumanlivertransplantationametaanalysis
AT zhangyangmin hypothermicmachineperfusionreducestheincidencesofearlyallograftdysfunctionandbiliarycomplicationsandimproves1yeargraftsurvivalafterhumanlivertransplantationametaanalysis
AT zhangmei hypothermicmachineperfusionreducestheincidencesofearlyallograftdysfunctionandbiliarycomplicationsandimproves1yeargraftsurvivalafterhumanlivertransplantationametaanalysis
AT mazhenhua hypothermicmachineperfusionreducestheincidencesofearlyallograftdysfunctionandbiliarycomplicationsandimproves1yeargraftsurvivalafterhumanlivertransplantationametaanalysis
AT wushengli hypothermicmachineperfusionreducestheincidencesofearlyallograftdysfunctionandbiliarycomplicationsandimproves1yeargraftsurvivalafterhumanlivertransplantationametaanalysis